Ovarian Cancer

Ovarian Cancer News

  • J&J Ordered to Pay $417 Million in Trial Over Talc Cancer Risks Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.
  • 'Liquid Biopsy' Spots Early-stage Cancers in Blood A test that scans blood for tumor-specific DNA identified early-stage cancer in more than half of 138 patients with the disease, U.S. researchers reported on Wednesday, marking a new milestone in the rush for so-called "liquid biopsies."
 

Ovarian Cancer Perspective

 

Journals